市場調查報告書
商品編碼
1036692

OTC抗感染疾病產品的全球市場:考察與預測 (2027年)

Global OTC Anti-Infective Products Market Insights and Forecast to 2027

出版日期: | 出版商: QYResearch | 英文 107 Pages | 商品交期: 2-3個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

  • 全貌
  • 簡介
  • 目錄
簡介

全球OTC抗感染疾病產品的市場規模在2020年估算為130億2,000萬美元。

此外在2021年∼2027年間預計將以3.4%的年複合成長率增長,到2027年末達到162億7,000萬美元。

本報告提供全球OTC抗感染疾病產品的市場相關分析,提供各類型·各銷售管道·各地區的市場趨勢預測 (2016年∼2027年) 、主要企業的簡介等相關調查。

目錄

第1章 分析範圍

  • OTC抗感染疾病產品:產品概要
  • 不同種類的市場
    • 市場規模·成長率:各類型
    • 抗真菌劑
    • 抗菌
    • 抗病毒藥
    • 消毒劑
    • 其他
  • 各銷售管道的市場
    • 市場規模·成長率:各銷售管道
    • 醫院藥局
    • 零售藥局
    • 線上藥局
  • 分析對象
  • 分析期間

第2章 摘要整理

  • 全球OTC抗感染疾病產品銷售 (2016年∼2027年)
  • 全球OTC抗感染疾病產品的收益 (2016年∼2027年)
  • 各地區的收益 (2016年/2021年/2027年)
  • 主要地區銷售趨勢
    • 銷售,實際成果值:各地區 (2016年∼2021年)
    • 銷售,預測值:各地區 (2022年∼2027年)
  • 主要地區的收益趨勢
    • 收益,實際成果值:各地區 (2016年∼2021年)
    • 收益,預測值:各地區 (2022年∼2027年)
  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 中東·非洲

第3章 廠商間的市場競爭

  • 各製造廠商銷售趨勢
    • 銷售:各製造廠商 (2016年∼2021年)
    • 銷售佔有率:各製造廠商 (2016年∼2021年)
    • 前十大企業·前5企業銷售 (2020年)
  • 各製造廠商的收益趨勢
    • 收益:各製造廠商 (2016年∼2021年)
    • 收益佔有率:各製造廠商 (2016年∼2021年)
    • 前十大企業·前5企業的收益 (2020年)
  • 各製造廠商銷售價格
  • 競爭情形分析
    • 市場集中度 (CR5,HHI)
    • 市場佔有率:各企業類型 (第一級,第二級,第三級)
    • 全球OTC抗感染疾病產品製造商位置趨勢
  • 企業合併·收購 (M&A)/事業擴張計劃

第4章 不同種類的市場規模

  • 不同種類的銷售趨勢
    • 銷售,實際成果值:各類型 (2016年∼2021年)
    • 銷售,預測值:各類型 (2022年∼2027年)
    • 銷售佔有率:各類型 (2016年∼2027年)
  • 不同種類的收益趨勢
    • 收益,實際成果值:各類型 (2016年∼2021年)
    • 收益,預測值:各類型 (2022年∼2027年)
    • 收益佔有率:各類型 (2016年∼2027年)
  • 不同種類的價格趨勢
    • 價格,實際成果值:各類型 (2016年∼2021年)
    • 價格,預測值:各類型 (2022年∼2027年)

第5章 各銷售管道的市場規模

  • 各銷售管道銷售趨勢
    • 銷售,實際成果值:各銷售管道 (2016年∼2021年)
    • 銷售,預測值:各銷售管道 (2022年∼2027年)
    • 銷售佔有率:各銷售管道 (2016年∼2027年)
  • 各銷售管道的收益趨勢
    • 收益,實際成果值:各銷售管道 (2016年∼2021年)
    • 收益,預測值:各銷售管道 (2022年∼2027年)
    • 收益佔有率:各銷售管道 (2016年∼2027年)
  • 各銷售管道的價格趨勢
    • 價格,實際成果值:各銷售管道 (2016年∼2021年)
    • 價格,預測值:各銷售管道 (2022年∼2027年)

第6章 北美

  • 不同種類的市場規模
    • 銷售:各類型 (2016年∼2027年)
    • 收益:各類型 (2016年∼2027年)
  • 各銷售管道的市場規模
    • 銷售:各銷售管道 (2016年∼2027年)
    • 收益:各銷售管道 (2016年∼2027年)
  • 各國銷售趨勢
    • 銷售:各國 (2016年∼2027年)
    • 收益:各國 (2016年∼2027年)
    • 美國
    • 加拿大

第7章 歐洲

  • 不同種類的市場規模
  • 各銷售管道的市場規模
  • 各國銷售趨勢
    • 德國
    • 法國
    • 英國
    • 義大利
    • 俄羅斯

第8章 亞太地區

  • 不同種類的市場規模
  • 各銷售管道的市場規模
  • 各地區的銷售趨勢
    • 中國
    • 日本
    • 韓國
    • 印度
    • 澳洲
    • 台灣
    • 印尼
    • 泰國
    • 馬來西亞

第9章 南美

  • 不同種類的市場規模
  • 各銷售管道的市場規模
  • 各國銷售趨勢
    • 墨西哥
    • 巴西
    • 阿根廷

第10章 中東·非洲

  • 不同種類的市場規模
  • 各銷售管道的市場規模
  • 各國銷售趨勢
    • 土耳其
    • 沙烏地阿拉伯

第11章 企業簡介

  • Bayer
  • GSK
  • Teva
  • Johnson &Johnson
  • NOVARTIS
  • MYLAN
  • Sun Pharma
  • CR SANJIU
  • Cipla
  • Lingrui

第12章 產業鏈和銷售管道分析

  • OTC抗感染疾病產品的產業鏈分析
  • OTC抗感染疾病產品的主要原料
    • 主要原料
    • 原料的主要供應商
  • OTC抗感染疾病產品的生產手法和工程
  • OTC抗感染疾病產品銷售·行銷
    • OTC抗感染疾病產品的銷售管道
    • OTC抗感染疾病產品的經銷商
  • OTC抗感染疾病產品客戶

第13章 市場促進因素·機會·課題·風險要素分析

  • OTC抗感染疾病產品產業趨勢
  • OTC抗感染疾病產品市場促進因素
  • OTC抗感染疾病產品市場課題
  • OTC抗感染疾病產品市場阻礙因素

第14章 全球OTC抗感染疾病產品市場:主要的分析結果

第15章 附錄

目錄

Anti-infectives are medicines that work to prevent or treat infections.

Anti-infective drugs used for the purpose of killing or suppressing the infection causing organisms from invading the host by means of its replication or releasing variety of toxins into the host. Infection causing micro-organisms include bacteria, viruses, fungi, viroids, and macro parasites.

Global core OTC anti-infective products manufacturers include Teva, MYLAN and NOVARTIS etc. The Top 3 companies hold a share above 10%. Asia-Pacific is the largest market, with a share about 38%, followed by North America and Europe with the share about 30% and 20%.

Market Analysis and Insights: Global OTC Anti-Infective Products Market

The global OTC Anti-Infective Products market is valued at US$ 13020 million in 2020. The market size will reach US$ 16270 million by the end of 2027, growing at a CAGR of 3.4% during 2021-2027.

Global OTC Anti-Infective Products Scope and Segment

OTC Anti-Infective Products market is segmented by Type, and by Sales Channel. Players, stakeholders, and other participants in the global OTC Anti-Infective Products market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Sales Channel for the period 2016-2027.

Segment by Type

  • Antifungal
  • Antibacterial
  • Antiviral
  • Antiseptics
  • Others

Segment by Sales Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

By Company

  • Bayer
  • GSK
  • Teva
  • Johnson & Johnson
  • NOVARTIS
  • MYLAN
  • Sun Pharma
  • CR SANJIU
  • Cipla
  • Lingrui

By Region

  • North America
    • United States
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • India
    • Australia
    • China Taiwan
    • Indonesia
    • Thailand
    • Malaysia
  • Latin America
    • Mexico
    • Brazil
    • Argentina
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE

TABLE OF CONTENTS

1 Study Coverage

  • 1.1 OTC Anti-Infective Products Product Introduction
  • 1.2 Market by Type
    • 1.2.1 Global OTC Anti-Infective Products Market Size Growth Rate by Type
    • 1.2.2 Antifungal
    • 1.2.3 Antibacterial
    • 1.2.4 Antiviral
    • 1.2.5 Antiseptics
    • 1.2.6 Others
  • 1.3 Market by Sales Channel
    • 1.3.1 Global OTC Anti-Infective Products Market Size Growth Rate by Sales Channel
    • 1.3.2 Hospital Pharmacies
    • 1.3.3 Retail Pharmacies
    • 1.3.4 Online Pharmacies
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Executive Summary

  • 2.1 Global OTC Anti-Infective Products Sales Estimates and Forecasts 2016-2027
  • 2.2 Global OTC Anti-Infective Products Revenue Estimates and Forecasts 2016-2027
  • 2.3 Global OTC Anti-Infective Products Revenue by Region: 2016 VS 2021 VS 2027
  • 2.4 Global Top OTC Anti-Infective Products Regions by Sales
    • 2.4.1 Global Top OTC Anti-Infective Products Regions by Sales (2016-2021)
    • 2.4.2 Global Top OTC Anti-Infective Products Regions by Sales (2022-2027)
  • 2.5 Global Top OTC Anti-Infective Products Regions by Revenue
    • 2.5.1 Global Top OTC Anti-Infective Products Regions by Revenue (2016-2021)
    • 2.5.2 Global Top OTC Anti-Infective Products Regions by Revenue (2022-2027)
  • 2.6 North America
  • 2.7 Europe
  • 2.8 Asia-Pacific
  • 2.9 Latin America
  • 2.10 Middle East & Africa

3 Competition by Manufacturers

  • 3.1 Global OTC Anti-Infective Products Sales by Manufacturers
    • 3.1.1 Global Top OTC Anti-Infective Products Manufacturers by Sales (2016-2021)
    • 3.1.2 Global Top OTC Anti-Infective Products Manufacturers Market Share by Sales (2016-2021)
    • 3.1.3 Global Top 10 and Top 5 Companies by OTC Anti-Infective Products Sales in 2020
  • 3.2 Global OTC Anti-Infective Products Revenue by Manufacturers
    • 3.2.1 Global Top OTC Anti-Infective Products Manufacturers by Revenue (2016-2021)
    • 3.2.2 Global Top OTC Anti-Infective Products Manufacturers Market Share by Revenue (2016-2021)
    • 3.2.3 Global Top 10 and Top 5 Companies by OTC Anti-Infective Products Revenue in 2020
  • 3.3 Global OTC Anti-Infective Products Sales Price by Manufacturers
  • 3.4 Analysis of Competitive Landscape
    • 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global OTC Anti-Infective Products Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    • 3.4.3 Global OTC Anti-Infective Products Manufacturers Geographical Distribution
  • 3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

  • 4.1 Global OTC Anti-Infective Products Sales by Type
    • 4.1.1 Global OTC Anti-Infective Products Historical Sales by Type (2016-2021)
    • 4.1.2 Global OTC Anti-Infective Products Forecasted Sales by Type (2022-2027)
    • 4.1.3 Global OTC Anti-Infective Products Sales Market Share by Type (2016-2027)
  • 4.2 Global OTC Anti-Infective Products Revenue by Type
    • 4.2.1 Global OTC Anti-Infective Products Historical Revenue by Type (2016-2021)
    • 4.2.2 Global OTC Anti-Infective Products Forecasted Revenue by Type (2022-2027)
    • 4.2.3 Global OTC Anti-Infective Products Revenue Market Share by Type (2016-2027)
  • 4.3 Global OTC Anti-Infective Products Price by Type
    • 4.3.1 Global OTC Anti-Infective Products Price by Type (2016-2021)
    • 4.3.2 Global OTC Anti-Infective Products Price Forecast by Type (2022-2027)

5 Market Size by Application

  • 5.1 Global OTC Anti-Infective Products Sales by Sales Channel
    • 5.1.1 Global OTC Anti-Infective Products Historical Sales by Sales Channel (2016-2021)
    • 5.1.2 Global OTC Anti-Infective Products Forecasted Sales by Sales Channel (2022-2027)
    • 5.1.3 Global OTC Anti-Infective Products Sales Market Share by Sales Channel (2016-2027)
  • 5.2 Global OTC Anti-Infective Products Revenue by Sales Channel
    • 5.2.1 Global OTC Anti-Infective Products Historical Revenue by Sales Channel (2016-2021)
    • 5.2.2 Global OTC Anti-Infective Products Forecasted Revenue by Sales Channel (2022-2027)
    • 5.2.3 Global OTC Anti-Infective Products Revenue Market Share by Sales Channel (2016-2027)
  • 5.3 Global OTC Anti-Infective Products Price by Sales Channel
    • 5.3.1 Global OTC Anti-Infective Products Price by Sales Channel (2016-2021)
    • 5.3.2 Global OTC Anti-Infective Products Price Forecast by Sales Channel (2022-2027)

6 North America

  • 6.1 North America OTC Anti-Infective Products Market Size by Type
    • 6.1.1 North America OTC Anti-Infective Products Sales by Type (2016-2027)
    • 6.1.2 North America OTC Anti-Infective Products Revenue by Type (2016-2027)
  • 6.2 North America OTC Anti-Infective Products Market Size by Sales Channel
    • 6.2.1 North America OTC Anti-Infective Products Sales by Sales Channel (2016-2027)
    • 6.2.2 North America OTC Anti-Infective Products Revenue by Sales Channel (2016-2027)
  • 6.3 North America OTC Anti-Infective Products Market Size by Country
    • 6.3.1 North America OTC Anti-Infective Products Sales by Country (2016-2027)
    • 6.3.2 North America OTC Anti-Infective Products Revenue by Country (2016-2027)
    • 6.3.3 United States
    • 6.3.4 Canada

7 Europe

  • 7.1 Europe OTC Anti-Infective Products Market Size by Type
    • 7.1.1 Europe OTC Anti-Infective Products Sales by Type (2016-2027)
    • 7.1.2 Europe OTC Anti-Infective Products Revenue by Type (2016-2027)
  • 7.2 Europe OTC Anti-Infective Products Market Size by Sales Channel
    • 7.2.1 Europe OTC Anti-Infective Products Sales by Sales Channel (2016-2027)
    • 7.2.2 Europe OTC Anti-Infective Products Revenue by Sales Channel (2016-2027)
  • 7.3 Europe OTC Anti-Infective Products Market Size by Country
    • 7.3.1 Europe OTC Anti-Infective Products Sales by Country (2016-2027)
    • 7.3.2 Europe OTC Anti-Infective Products Revenue by Country (2016-2027)
    • 7.3.3 Germany
    • 7.3.4 France
    • 7.3.5 U.K.
    • 7.3.6 Italy
    • 7.3.7 Russia

8 Asia Pacific

  • 8.1 Asia Pacific OTC Anti-Infective Products Market Size by Type
    • 8.1.1 Asia Pacific OTC Anti-Infective Products Sales by Type (2016-2027)
    • 8.1.2 Asia Pacific OTC Anti-Infective Products Revenue by Type (2016-2027)
  • 8.2 Asia Pacific OTC Anti-Infective Products Market Size by Sales Channel
    • 8.2.1 Asia Pacific OTC Anti-Infective Products Sales by Sales Channel (2016-2027)
    • 8.2.2 Asia Pacific OTC Anti-Infective Products Revenue by Sales Channel (2016-2027)
  • 8.3 Asia Pacific OTC Anti-Infective Products Market Size by Region
    • 8.3.1 Asia Pacific OTC Anti-Infective Products Sales by Region (2016-2027)
    • 8.3.2 Asia Pacific OTC Anti-Infective Products Revenue by Region (2016-2027)
    • 8.3.3 China
    • 8.3.4 Japan
    • 8.3.5 South Korea
    • 8.3.6 India
    • 8.3.7 Australia
    • 8.3.8 China Taiwan
    • 8.3.9 Indonesia
    • 8.3.10 Thailand
    • 8.3.11 Malaysia

9 Latin America

  • 9.1 Latin America OTC Anti-Infective Products Market Size by Type
    • 9.1.1 Latin America OTC Anti-Infective Products Sales by Type (2016-2027)
    • 9.1.2 Latin America OTC Anti-Infective Products Revenue by Type (2016-2027)
  • 9.2 Latin America OTC Anti-Infective Products Market Size by Sales Channel
    • 9.2.1 Latin America OTC Anti-Infective Products Sales by Sales Channel (2016-2027)
    • 9.2.2 Latin America OTC Anti-Infective Products Revenue by Sales Channel (2016-2027)
  • 9.3 Latin America OTC Anti-Infective Products Market Size by Country
    • 9.3.1 Latin America OTC Anti-Infective Products Sales by Country (2016-2027)
    • 9.3.2 Latin America OTC Anti-Infective Products Revenue by Country (2016-2027)
    • 9.3.3 Mexico
    • 9.3.4 Brazil
    • 9.3.5 Argentina

10 Middle East and Africa

  • 10.1 Middle East and Africa OTC Anti-Infective Products Market Size by Type
    • 10.1.1 Middle East and Africa OTC Anti-Infective Products Sales by Type (2016-2027)
    • 10.1.2 Middle East and Africa OTC Anti-Infective Products Revenue by Type (2016-2027)
  • 10.2 Middle East and Africa OTC Anti-Infective Products Market Size by Sales Channel
    • 10.2.1 Middle East and Africa OTC Anti-Infective Products Sales by Sales Channel (2016-2027)
    • 10.2.2 Middle East and Africa OTC Anti-Infective Products Revenue by Sales Channel (2016-2027)
  • 10.3 Middle East and Africa OTC Anti-Infective Products Market Size by Country
    • 10.3.1 Middle East and Africa OTC Anti-Infective Products Sales by Country (2016-2027)
    • 10.3.2 Middle East and Africa OTC Anti-Infective Products Revenue by Country (2016-2027)
    • 10.3.3 Turkey
    • 10.3.4 Saudi Arabia

11 Company Profiles

  • 11.1 Bayer
    • 11.1.1 Bayer Corporation Information
    • 11.1.2 Bayer Overview
    • 11.1.3 Bayer OTC Anti-Infective Products Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.1.4 Bayer OTC Anti-Infective Products Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.1.5 Bayer Recent Developments
  • 11.2 GSK
    • 11.2.1 GSK Corporation Information
    • 11.2.2 GSK Overview
    • 11.2.3 GSK OTC Anti-Infective Products Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.2.4 GSK OTC Anti-Infective Products Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.2.5 GSK Recent Developments
  • 11.3 Teva
    • 11.3.1 Teva Corporation Information
    • 11.3.2 Teva Overview
    • 11.3.3 Teva OTC Anti-Infective Products Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.3.4 Teva OTC Anti-Infective Products Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.3.5 Teva Recent Developments
  • 11.4 Johnson & Johnson
    • 11.4.1 Johnson & Johnson Corporation Information
    • 11.4.2 Johnson & Johnson Overview
    • 11.4.3 Johnson & Johnson OTC Anti-Infective Products Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.4.4 Johnson & Johnson OTC Anti-Infective Products Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.4.5 Johnson & Johnson Recent Developments
  • 11.5 NOVARTIS
    • 11.5.1 NOVARTIS Corporation Information
    • 11.5.2 NOVARTIS Overview
    • 11.5.3 NOVARTIS OTC Anti-Infective Products Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.5.4 NOVARTIS OTC Anti-Infective Products Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.5.5 NOVARTIS Recent Developments
  • 11.6 MYLAN
    • 11.6.1 MYLAN Corporation Information
    • 11.6.2 MYLAN Overview
    • 11.6.3 MYLAN OTC Anti-Infective Products Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.6.4 MYLAN OTC Anti-Infective Products Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.6.5 MYLAN Recent Developments
  • 11.7 Sun Pharma
    • 11.7.1 Sun Pharma Corporation Information
    • 11.7.2 Sun Pharma Overview
    • 11.7.3 Sun Pharma OTC Anti-Infective Products Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.7.4 Sun Pharma OTC Anti-Infective Products Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.7.5 Sun Pharma Recent Developments
  • 11.8 CR SANJIU
    • 11.8.1 CR SANJIU Corporation Information
    • 11.8.2 CR SANJIU Overview
    • 11.8.3 CR SANJIU OTC Anti-Infective Products Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.8.4 CR SANJIU OTC Anti-Infective Products Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.8.5 CR SANJIU Recent Developments
  • 11.9 Cipla
    • 11.9.1 Cipla Corporation Information
    • 11.9.2 Cipla Overview
    • 11.9.3 Cipla OTC Anti-Infective Products Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.9.4 Cipla OTC Anti-Infective Products Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.9.5 Cipla Recent Developments
  • 11.10 Lingrui
    • 11.10.1 Lingrui Corporation Information
    • 11.10.2 Lingrui Overview
    • 11.10.3 Lingrui OTC Anti-Infective Products Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.10.4 Lingrui OTC Anti-Infective Products Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.10.5 Lingrui Recent Developments

12 Value Chain and Sales Channels Analysis

  • 12.1 OTC Anti-Infective Products Value Chain Analysis
  • 12.2 OTC Anti-Infective Products Key Raw Materials
    • 12.2.1 Key Raw Materials
    • 12.2.2 Raw Materials Key Suppliers
  • 12.3 OTC Anti-Infective Products Production Mode & Process
  • 12.4 OTC Anti-Infective Products Sales and Marketing
    • 12.4.1 OTC Anti-Infective Products Sales Channels
    • 12.4.2 OTC Anti-Infective Products Distributors
  • 12.5 OTC Anti-Infective Products Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

  • 13.1 OTC Anti-Infective Products Industry Trends
  • 13.2 OTC Anti-Infective Products Market Drivers
  • 13.3 OTC Anti-Infective Products Market Challenges
  • 13.4 OTC Anti-Infective Products Market Restraints

14 Key Findings in The Global OTC Anti-Infective Products Study

15 Appendix

  • 15.1 Research Methodology
    • 15.1.1 Methodology/Research Approach
    • 15.1.2 Data Source
  • 15.2 Author Details
  • 15.3 Disclaimer

List of Tables

List of Tables

  • Table 1. Global OTC Anti-Infective Products Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
  • Table 2. Major Manufacturers of Antifungal
  • Table 3. Major Manufacturers of Antibacterial
  • Table 4. Major Manufacturers of Antiviral
  • Table 5. Major Manufacturers of Antiseptics
  • Table 6. Major Manufacturers of Others
  • Table 7. Global OTC Anti-Infective Products Market Size Growth Rate by Sales Channel, 2016 VS 2021 VS 2027 (US$ Million)
  • Table 8. Global OTC Anti-Infective Products Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million)
  • Table 9. Global OTC Anti-Infective Products Sales by Region (2016-2021) & (M Units)
  • Table 10. Global OTC Anti-Infective Products Sales Market Share by Region (2016-2021)
  • Table 11. Global OTC Anti-Infective Products Sales by Region (2022-2027) & (M Units)
  • Table 12. Global OTC Anti-Infective Products Sales Market Share by Region (2022-2027)
  • Table 13. Global OTC Anti-Infective Products Revenue by Region (2016-2021) & (US$ Million)
  • Table 14. Global OTC Anti-Infective Products Revenue Market Share by Region (2016-2021)
  • Table 15. Global OTC Anti-Infective Products Revenue by Region (2022-2027) & (US$ Million)
  • Table 16. Global OTC Anti-Infective Products Revenue Market Share by Region (2022-2027)
  • Table 17. Global OTC Anti-Infective Products Sales by Manufacturers (2016-2021) & (M Units)
  • Table 18. Global OTC Anti-Infective Products Sales Share by Manufacturers (2016-2021)
  • Table 19. Global OTC Anti-Infective Products Revenue by Manufacturers (2016-2021) & (US$ Million)
  • Table 20. Global OTC Anti-Infective Products Revenue Share by Manufacturers (2016-2021)
  • Table 21. OTC Anti-Infective Products Price by Manufacturers 2016-2021 (US$/Unit)
  • Table 22. Global OTC Anti-Infective Products Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table 23. Global OTC Anti-Infective Products by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in OTC Anti-Infective Products as of 2020)
  • Table 24. OTC Anti-Infective Products Manufacturing Base Distribution and Headquarters
  • Table 25. Manufacturers OTC Anti-Infective Products Product Offered
  • Table 26. Date of Manufacturers Enter into OTC Anti-Infective Products Market
  • Table 27. Mergers & Acquisitions, Expansion Plans
  • Table 28. Global OTC Anti-Infective Products Sales by Type (2016-2021) & (M Units)
  • Table 29. Global OTC Anti-Infective Products Sales by Type (2022-2027) & (M Units)
  • Table 30. Global OTC Anti-Infective Products Sales Share by Type (2016-2021)
  • Table 31. Global OTC Anti-Infective Products Sales Share by Type (2022-2027)
  • Table 32. Global OTC Anti-Infective Products Revenue by Type (2016-2021) & (US$ Million)
  • Table 33. Global OTC Anti-Infective Products Revenue by Type (2022-2027) & (US$ Million)
  • Table 34. Global OTC Anti-Infective Products Revenue Share by Type (2016-2021)
  • Table 35. Global OTC Anti-Infective Products Revenue Share by Type (2022-2027)
  • Table 36. OTC Anti-Infective Products Price by Type (2016-2021) & (US$/Unit)
  • Table 37. Global OTC Anti-Infective Products Price Forecast by Type (2022-2027) & (US$/Unit)
  • Table 38. Global OTC Anti-Infective Products Sales by Sales Channel (2016-2021) & (M Units)
  • Table 39. Global OTC Anti-Infective Products Sales by Sales Channel (2022-2027) & (M Units)
  • Table 40. Global OTC Anti-Infective Products Sales Share by Sales Channel (2016-2021)
  • Table 41. Global OTC Anti-Infective Products Sales Share by Sales Channel (2022-2027)
  • Table 42. Global OTC Anti-Infective Products Revenue by Sales Channel (2016-2021) & (US$ Million)
  • Table 43. Global OTC Anti-Infective Products Revenue by Sales Channel (2022-2027) & (US$ Million)
  • Table 44. Global OTC Anti-Infective Products Revenue Share by Sales Channel (2016-2021)
  • Table 45. Global OTC Anti-Infective Products Revenue Share by Sales Channel (2022-2027)
  • Table 46. OTC Anti-Infective Products Price by Sales Channel (2016-2021) & (US$/Unit)
  • Table 47. Global OTC Anti-Infective Products Price Forecast by Sales Channel (2022-2027) & (US$/Unit)
  • Table 48. North America OTC Anti-Infective Products Sales by Type (2016-2021) & (M Units)
  • Table 49. North America OTC Anti-Infective Products Sales by Type (2022-2027) & (M Units)
  • Table 50. North America OTC Anti-Infective Products Revenue by Type (2016-2021) & (US$ Million)
  • Table 51. North America OTC Anti-Infective Products Revenue by Type (2022-2027) & (US$ Million)
  • Table 52. North America OTC Anti-Infective Products Sales by Sales Channel (2016-2021) & (M Units)
  • Table 53. North America OTC Anti-Infective Products Sales by Sales Channel (2022-2027) & (M Units)
  • Table 54. North America OTC Anti-Infective Products Revenue by Sales Channel (2016-2021) & (US$ Million)
  • Table 55. North America OTC Anti-Infective Products Revenue by Sales Channel (2022-2027) & (US$ Million)
  • Table 56. North America OTC Anti-Infective Products Sales by Country (2016-2021) & (M Units)
  • Table 57. North America OTC Anti-Infective Products Sales by Country (2022-2027) & (M Units)
  • Table 58. North America OTC Anti-Infective Products Revenue by Country (2016-2021) & (US$ Million)
  • Table 59. North America OTC Anti-Infective Products Revenue by Country (2022-2027) & (US$ Million)
  • Table 60. Europe OTC Anti-Infective Products Sales by Type (2016-2021) & (M Units)
  • Table 61. Europe OTC Anti-Infective Products Sales by Type (2022-2027) & (M Units)
  • Table 62. Europe OTC Anti-Infective Products Revenue by Type (2016-2021) & (US$ Million)
  • Table 63. Europe OTC Anti-Infective Products Revenue by Type (2022-2027) & (US$ Million)
  • Table 64. Europe OTC Anti-Infective Products Sales by Sales Channel (2016-2021) & (M Units)
  • Table 65. Europe OTC Anti-Infective Products Sales by Sales Channel (2022-2027) & (M Units)
  • Table 66. Europe OTC Anti-Infective Products Revenue by Sales Channel (2016-2021) & (US$ Million)
  • Table 67. Europe OTC Anti-Infective Products Revenue by Sales Channel (2022-2027) & (US$ Million)
  • Table 68. Europe OTC Anti-Infective Products Sales by Country (2016-2021) & (M Units)
  • Table 69. Europe OTC Anti-Infective Products Sales by Country (2022-2027) & (M Units)
  • Table 70. Europe OTC Anti-Infective Products Revenue by Country (2016-2021) & (US$ Million)
  • Table 71. Europe OTC Anti-Infective Products Revenue by Country (2022-2027) & (US$ Million)
  • Table 72. Asia Pacific OTC Anti-Infective Products Sales by Type (2016-2021) & (M Units)
  • Table 73. Asia Pacific OTC Anti-Infective Products Sales by Type (2022-2027) & (M Units)
  • Table 74. Asia Pacific OTC Anti-Infective Products Revenue by Type (2016-2021) & (US$ Million)
  • Table 75. Asia Pacific OTC Anti-Infective Products Revenue by Type (2022-2027) & (US$ Million)
  • Table 76. Asia Pacific OTC Anti-Infective Products Sales by Sales Channel (2016-2021) & (M Units)
  • Table 77. Asia Pacific OTC Anti-Infective Products Sales by Sales Channel (2022-2027) & (M Units)
  • Table 78. Asia Pacific OTC Anti-Infective Products Revenue by Sales Channel (2016-2021) & (US$ Million)
  • Table 79. Asia Pacific OTC Anti-Infective Products Revenue by Sales Channel (2022-2027) & (US$ Million)
  • Table 80. Asia Pacific OTC Anti-Infective Products Sales by Region (2016-2021) & (M Units)
  • Table 81. Asia Pacific OTC Anti-Infective Products Sales by Region (2022-2027) & (M Units)
  • Table 82. Asia Pacific OTC Anti-Infective Products Revenue by Region (2016-2021) & (US$ Million)
  • Table 83. Asia Pacific OTC Anti-Infective Products Revenue by Region (2022-2027) & (US$ Million)
  • Table 84. Latin America OTC Anti-Infective Products Sales by Type (2016-2021) & (M Units)
  • Table 85. Latin America OTC Anti-Infective Products Sales by Type (2022-2027) & (M Units)
  • Table 86. Latin America OTC Anti-Infective Products Revenue by Type (2016-2021) & (US$ Million)
  • Table 87. Latin America OTC Anti-Infective Products Revenue by Type (2022-2027) & (US$ Million)
  • Table 88. Latin America OTC Anti-Infective Products Sales by Sales Channel (2016-2021) & (M Units)
  • Table 89. Latin America OTC Anti-Infective Products Sales by Sales Channel (2022-2027) & (M Units)
  • Table 90. Latin America OTC Anti-Infective Products Revenue by Sales Channel (2016-2021) & (US$ Million)
  • Table 91. Latin America OTC Anti-Infective Products Revenue by Sales Channel (2022-2027) & (US$ Million)
  • Table 92. Latin America OTC Anti-Infective Products Sales by Country (2016-2021) & (M Units)
  • Table 93. Latin America OTC Anti-Infective Products Sales by Country (2022-2027) & (M Units)
  • Table 94. Latin America OTC Anti-Infective Products Revenue by Country (2016-2021) & (US$ Million)
  • Table 95. Latin America OTC Anti-Infective Products Revenue by Country (2022-2027) & (US$ Million)
  • Table 96. Middle East and Africa OTC Anti-Infective Products Sales by Type (2016-2021) & (M Units)
  • Table 97. Middle East and Africa OTC Anti-Infective Products Sales by Type (2022-2027) & (M Units)
  • Table 98. Middle East and Africa OTC Anti-Infective Products Revenue by Type (2016-2021) & (US$ Million)
  • Table 99. Middle East and Africa OTC Anti-Infective Products Revenue by Type (2022-2027) & (US$ Million)
  • Table 100. Middle East and Africa OTC Anti-Infective Products Sales by Sales Channel (2016-2021) & (M Units)
  • Table 101. Middle East and Africa OTC Anti-Infective Products Sales by Sales Channel (2022-2027) & (M Units)
  • Table 102. Middle East and Africa OTC Anti-Infective Products Revenue by Sales Channel (2016-2021) & (US$ Million)
  • Table 103. Middle East and Africa OTC Anti-Infective Products Revenue by Sales Channel (2022-2027) & (US$ Million)
  • Table 104. Middle East and Africa OTC Anti-Infective Products Sales by Country (2016-2021) & (M Units)
  • Table 105. Middle East and Africa OTC Anti-Infective Products Sales by Country (2022-2027) & (M Units)
  • Table 106. Middle East and Africa OTC Anti-Infective Products Revenue by Country (2016-2021) & (US$ Million)
  • Table 107. Middle East and Africa OTC Anti-Infective Products Revenue by Country (2022-2027) & (US$ Million)
  • Table 108. Bayer Corporation Information
  • Table 109. Bayer Description and Major Businesses
  • Table 110. Bayer OTC Anti-Infective Products Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
  • Table 111. Bayer OTC Anti-Infective Products Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 112. Bayer Recent Developments
  • Table 113. GSK Corporation Information
  • Table 114. GSK Description and Major Businesses
  • Table 115. GSK OTC Anti-Infective Products Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
  • Table 116. GSK OTC Anti-Infective Products Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 117. GSK Recent Developments
  • Table 118. Teva Corporation Information
  • Table 119. Teva Description and Major Businesses
  • Table 120. Teva OTC Anti-Infective Products Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
  • Table 121. Teva OTC Anti-Infective Products Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 122. Teva Recent Developments
  • Table 123. Johnson & Johnson Corporation Information
  • Table 124. Johnson & Johnson Description and Major Businesses
  • Table 125. Johnson & Johnson OTC Anti-Infective Products Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
  • Table 126. Johnson & Johnson OTC Anti-Infective Products Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 127. Johnson & Johnson Recent Developments
  • Table 128. NOVARTIS Corporation Information
  • Table 129. NOVARTIS Description and Major Businesses
  • Table 130. NOVARTIS OTC Anti-Infective Products Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
  • Table 131. NOVARTIS OTC Anti-Infective Products Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 132. NOVARTIS Recent Developments
  • Table 133. MYLAN Corporation Information
  • Table 134. MYLAN Description and Major Businesses
  • Table 135. MYLAN OTC Anti-Infective Products Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
  • Table 136. MYLAN OTC Anti-Infective Products Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 137. MYLAN Recent Developments
  • Table 138. Sun Pharma Corporation Information
  • Table 139. Sun Pharma Description and Major Businesses
  • Table 140. Sun Pharma OTC Anti-Infective Products Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
  • Table 141. Sun Pharma OTC Anti-Infective Products Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 142. Sun Pharma Recent Developments
  • Table 143. CR SANJIU Corporation Information
  • Table 144. CR SANJIU Description and Major Businesses
  • Table 145. CR SANJIU OTC Anti-Infective Products Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
  • Table 146. CR SANJIU OTC Anti-Infective Products Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 147. CR SANJIU Recent Developments
  • Table 148. Cipla Corporation Information
  • Table 149. Cipla Description and Major Businesses
  • Table 150. Cipla OTC Anti-Infective Products Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
  • Table 151. Cipla OTC Anti-Infective Products Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 152. Cipla Recent Developments
  • Table 153. Lingrui Corporation Information
  • Table 154. Lingrui Description and Major Businesses
  • Table 155. Lingrui OTC Anti-Infective Products Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
  • Table 156. Lingrui OTC Anti-Infective Products Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 157. Lingrui Recent Developments
  • Table 158. Key Raw Materials Lists
  • Table 159. Raw Materials Key Suppliers Lists
  • Table 160. OTC Anti-Infective Products Distributors List
  • Table 161. OTC Anti-Infective Products Customers List
  • Table 162. OTC Anti-Infective Products Market Trends
  • Table 163. OTC Anti-Infective Products Market Drivers
  • Table 164. OTC Anti-Infective Products Market Challenges
  • Table 165. OTC Anti-Infective Products Market Restraints
  • Table 166. Research Programs/Design for This Report
  • Table 167. Key Data Information from Secondary Sources
  • Table 168. Key Data Information from Primary Sources

List of Figures

  • Figure 1. OTC Anti-Infective Products Product Picture
  • Figure 3. Global OTC Anti-Infective Products Market Share by Type in 2020 & 2027
  • Figure 3. Antifungal Product Picture
  • Figure 4. Antibacterial Product Picture
  • Figure 5. Antiviral Product Picture
  • Figure 6. Antiseptics Product Picture
  • Figure 7. Others Product Picture
  • Figure 8. Global OTC Anti-Infective Products Market Share by Sales Channel in 2020 & 2027
  • Figure 9. Hospital Pharmacies
  • Figure 10. Retail Pharmacies
  • Figure 11. Online Pharmacies
  • Figure 12. OTC Anti-Infective Products Report Years Considered
  • Figure 13. Global OTC Anti-Infective Products Sales 2016-2027 (M Units)
  • Figure 14. Global OTC Anti-Infective Products Revenue, (US$ Million), 2016 VS 2021 VS 2027
  • Figure 15. Global OTC Anti-Infective Products Revenue 2016-2027 (US$ Million)
  • Figure 16. Global OTC Anti-Infective Products Revenue Market Share by Region in Percentage: 2020 Versus 2027
  • Figure 17. Global OTC Anti-Infective Products Sales Market Share by Region (2016-2021)
  • Figure 18. Global OTC Anti-Infective Products Sales Market Share by Region (2022-2027)
  • Figure 19. North America OTC Anti-Infective Products Sales YoY (2016-2027) & (M Units)
  • Figure 20. North America OTC Anti-Infective Products Revenue YoY (2016-2027) & (US$ Million)
  • Figure 21. Europe OTC Anti-Infective Products Sales YoY (2016-2027) & (M Units)
  • Figure 22. Europe OTC Anti-Infective Products Revenue YoY (2016-2027) & (US$ Million)
  • Figure 23. Asia-Pacific OTC Anti-Infective Products Sales YoY (2016-2027) & (M Units)
  • Figure 24. Asia-Pacific OTC Anti-Infective Products Revenue YoY (2016-2027) & (US$ Million)
  • Figure 25. Latin America OTC Anti-Infective Products Sales YoY (2016-2027) & (M Units)
  • Figure 26. Latin America OTC Anti-Infective Products Revenue YoY (2016-2027) & (US$ Million)
  • Figure 27. Middle East & Africa OTC Anti-Infective Products Sales YoY (2016-2027) & (M Units)
  • Figure 28. Middle East & Africa OTC Anti-Infective Products Revenue YoY (2016-2027) & (US$ Million)
  • Figure 29. The Top 10 and Top 5 Players Market Share by OTC Anti-Infective Products Sales in 2020
  • Figure 30. The Top 10 and Top 5 Players Market Share by OTC Anti-Infective Products Revenue in 2020
  • Figure 31. OTC Anti-Infective Products Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020
  • Figure 32. Global OTC Anti-Infective Products Sales Market Share by Type (2016-2027)
  • Figure 33. Global OTC Anti-Infective Products Revenue Market Share by Type (2016-2027)
  • Figure 34. Global OTC Anti-Infective Products Sales Market Share by Sales Channel (2016-2027)
  • Figure 35. Global OTC Anti-Infective Products Revenue Market Share by Sales Channel (2016-2027)
  • Figure 36. North America OTC Anti-Infective Products Sales Market Share by Type (2016-2027)
  • Figure 37. North America OTC Anti-Infective Products Revenue Market Share by Type (2016-2027)
  • Figure 38. North America OTC Anti-Infective Products Sales Market Share by Sales Channel (2016-2027)
  • Figure 39. North America OTC Anti-Infective Products Revenue Market Share by Sales Channel (2016-2027)
  • Figure 40. North America OTC Anti-Infective Products Sales Share by Country (2016-2027)
  • Figure 41. North America OTC Anti-Infective Products Revenue Share by Country (2016-2027)
  • Figure 42. United States OTC Anti-Infective Products Revenue (2016-2027) & (US$ Million)
  • Figure 43. Canada OTC Anti-Infective Products Revenue (2016-2027) & (US$ Million)
  • Figure 44. Europe OTC Anti-Infective Products Sales Market Share by Type (2016-2027)
  • Figure 45. Europe OTC Anti-Infective Products Revenue Market Share by Type (2016-2027)
  • Figure 46. Europe OTC Anti-Infective Products Sales Market Share by Sales Channel (2016-2027)
  • Figure 47. Europe OTC Anti-Infective Products Revenue Market Share by Sales Channel (2016-2027)
  • Figure 48. Europe OTC Anti-Infective Products Sales Share by Country (2016-2027)
  • Figure 49. Europe OTC Anti-Infective Products Revenue Share by Country (2016-2027)
  • Figure 50. Germany OTC Anti-Infective Products Revenue (2016-2027) & (US$ Million)
  • Figure 51. France OTC Anti-Infective Products Revenue (2016-2027) & (US$ Million)
  • Figure 52. U.K. OTC Anti-Infective Products Revenue (2016-2027) & (US$ Million)
  • Figure 53. Italy OTC Anti-Infective Products Revenue (2016-2027) & (US$ Million)
  • Figure 54. Russia OTC Anti-Infective Products Revenue (2016-2027) & (US$ Million)
  • Figure 55. Asia Pacific OTC Anti-Infective Products Sales Market Share by Type (2016-2027)
  • Figure 56. Asia Pacific OTC Anti-Infective Products Revenue Market Share by Type (2016-2027)
  • Figure 57. Asia Pacific OTC Anti-Infective Products Sales Market Share by Sales Channel (2016-2027)
  • Figure 58. Asia Pacific OTC Anti-Infective Products Revenue Market Share by Sales Channel (2016-2027)
  • Figure 59. Asia Pacific OTC Anti-Infective Products Sales Share by Region (2016-2027)
  • Figure 60. Asia Pacific OTC Anti-Infective Products Revenue Share by Region (2016-2027)
  • Figure 61. China OTC Anti-Infective Products Revenue (2016-2027) & (US$ Million)
  • Figure 62. Japan OTC Anti-Infective Products Revenue (2016-2027) & (US$ Million)
  • Figure 63. South Korea OTC Anti-Infective Products Revenue (2016-2027) & (US$ Million)
  • Figure 64. India OTC Anti-Infective Products Revenue (2016-2027) & (US$ Million)
  • Figure 65. Australia OTC Anti-Infective Products Revenue (2016-2027) & (US$ Million)
  • Figure 66. China Taiwan OTC Anti-Infective Products Revenue (2016-2027) & (US$ Million)
  • Figure 67. Indonesia OTC Anti-Infective Products Revenue (2016-2027) & (US$ Million)
  • Figure 68. Thailand OTC Anti-Infective Products Revenue (2016-2027) & (US$ Million)
  • Figure 69. Malaysia OTC Anti-Infective Products Revenue (2016-2027) & (US$ Million)
  • Figure 70. Latin America OTC Anti-Infective Products Sales Market Share by Type (2016-2027)
  • Figure 71. Latin America OTC Anti-Infective Products Revenue Market Share by Type (2016-2027)
  • Figure 72. Latin America OTC Anti-Infective Products Sales Market Share by Sales Channel (2016-2027)
  • Figure 73. Latin America OTC Anti-Infective Products Revenue Market Share by Sales Channel (2016-2027)
  • Figure 74. Latin America OTC Anti-Infective Products Sales Share by Country (2016-2027)
  • Figure 75. Latin America OTC Anti-Infective Products Revenue Share by Country (2016-2027)
  • Figure 76. Mexico OTC Anti-Infective Products Revenue (2016-2027) & (US$ Million)
  • Figure 77. Brazil OTC Anti-Infective Products Revenue (2016-2027) & (US$ Million)
  • Figure 78. Argentina OTC Anti-Infective Products Revenue (2016-2027) & (US$ Million)
  • Figure 79. Middle East and Africa OTC Anti-Infective Products Sales Market Share by Type (2016-2027)
  • Figure 80. Middle East and Africa OTC Anti-Infective Products Revenue Market Share by Type (2016-2027)
  • Figure 81. Middle East and Africa OTC Anti-Infective Products Sales Market Share by Sales Channel (2016-2027)
  • Figure 82. Middle East and Africa OTC Anti-Infective Products Revenue Market Share by Sales Channel (2016-2027)
  • Figure 83. Middle East and Africa OTC Anti-Infective Products Sales Share by Country (2016-2027)
  • Figure 84. Middle East and Africa OTC Anti-Infective Products Revenue Share by Country (2016-2027)
  • Figure 85. Turkey OTC Anti-Infective Products Revenue (2016-2027) & (US$ Million)
  • Figure 86. Saudi Arabia OTC Anti-Infective Products Revenue (2016-2027) & (US$ Million)
  • Figure 87. UAE OTC Anti-Infective Products Revenue (2016-2027) & (US$ Million)
  • Figure 88. OTC Anti-Infective Products Value Chain
  • Figure 89. OTC Anti-Infective Products Production Process
  • Figure 90. Channels of Distribution
  • Figure 91. Distributors Profiles
  • Figure 92. Bottom-up and Top-down Approaches for This Report
  • Figure 93. Data Triangulation
  • Figure 94. Key Executives Interviewed